176 related articles for article (PubMed ID: 22763559)
1. Negative regulation of cell motile and invasive activities by lysophosphatidic acid receptor-3 in colon cancer HCT116 cells.
Fukui R; Tanabe E; Kitayoshi M; Yoshikawa K; Fukushima N; Tsujiuchi T
Tumour Biol; 2012 Dec; 33(6):1899-905. PubMed ID: 22763559
[TBL] [Abstract][Full Text] [Related]
2. Lysophosphatidic acid signaling via LPA
Fukushima K; Takahashi K; Yamasaki E; Onishi Y; Fukushima N; Honoki K; Tsujiuchi T
Exp Cell Res; 2017 Mar; 352(1):139-145. PubMed ID: 28189636
[TBL] [Abstract][Full Text] [Related]
3. Loss of lysophosphatidic acid receptor-3 suppresses cell migration activity of human sarcoma cells.
Tanabe E; Kitayoshi M; Yoshikawa K; Shibata A; Honoki K; Fukushima N; Tsujiuchi T
J Recept Signal Transduct Res; 2012 Dec; 32(6):328-34. PubMed ID: 23167620
[TBL] [Abstract][Full Text] [Related]
4. Opposite roles of LPA1 and LPA3 on cell motile and invasive activities of pancreatic cancer cells.
Kato K; Yoshikawa K; Tanabe E; Kitayoshi M; Fukui R; Fukushima N; Tsujiuchi T
Tumour Biol; 2012 Oct; 33(5):1739-44. PubMed ID: 22678979
[TBL] [Abstract][Full Text] [Related]
5. β-Arrestin2 regulates lysophosphatidic acid-induced human breast tumor cell migration and invasion via Rap1 and IQGAP1.
Alemayehu M; Dragan M; Pape C; Siddiqui I; Sacks DB; Di Guglielmo GM; Babwah AV; Bhattacharya M
PLoS One; 2013; 8(2):e56174. PubMed ID: 23405264
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of endothelial cell migration by constitutively active LPA(1)-expressing tumor cells.
Kitayoshi M; Kato K; Tanabe E; Yoshikawa K; Fukui R; Fukushima N; Tsujiuchi T
Biochem Biophys Res Commun; 2012 Jun; 422(2):339-43. PubMed ID: 22580000
[TBL] [Abstract][Full Text] [Related]
7. Lysophosphatidic acid (LPA) signaling via LPA
Takahashi K; Fukushima K; Onishi Y; Inui K; Node Y; Fukushima N; Honoki K; Tsujiuchi T
Biochem Biophys Res Commun; 2017 Jan; 483(1):652-657. PubMed ID: 27993681
[TBL] [Abstract][Full Text] [Related]
8. Hydrogen peroxide stimulates cell motile activity through LPA receptor-3 in liver epithelial WB-F344 cells.
Shibata A; Tanabe E; Inoue S; Kitayoshi M; Okimoto S; Hirane M; Araki M; Fukushima N; Tsujiuchi T
Biochem Biophys Res Commun; 2013 Apr; 433(3):317-21. PubMed ID: 23510996
[TBL] [Abstract][Full Text] [Related]
9. Cross-talk between LPA1 and epidermal growth factor receptors mediates up-regulation of sphingosine kinase 1 to promote gastric cancer cell motility and invasion.
Shida D; Fang X; Kordula T; Takabe K; Lépine S; Alvarez SE; Milstien S; Spiegel S
Cancer Res; 2008 Aug; 68(16):6569-77. PubMed ID: 18701480
[TBL] [Abstract][Full Text] [Related]
10. Involvement of oncogenic K-ras on cell migration stimulated by lysophosphatidic acid receptor-2 in pancreatic cancer cells.
Yoshikawa K; Tanabe E; Shibata A; Inoue S; Kitayoshi M; Okimoto S; Fukushima N; Tsujiuchi T
Exp Cell Res; 2013 Feb; 319(3):105-12. PubMed ID: 23041208
[TBL] [Abstract][Full Text] [Related]
11. Lysophosphatidic acid upregulates vascular endothelial growth factor-C and tube formation in human endothelial cells through LPA(1/3), COX-2, and NF-kappaB activation- and EGFR transactivation-dependent mechanisms.
Lin CI; Chen CN; Huang MT; Lee SJ; Lin CH; Chang CC; Lee H
Cell Signal; 2008 Oct; 20(10):1804-14. PubMed ID: 18627789
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of activation factors of endothelia and fibroblasts via lysophosphatidic acid signaling in a mouse lung cancer LL/2 cell line.
Tanabe E; Kitayoshi M; Hirane M; Araki M; Dong Y; Fukushima N; Tsujiuchi T
J Recept Signal Transduct Res; 2013 Oct; 33(5):286-90. PubMed ID: 23909436
[TBL] [Abstract][Full Text] [Related]
13. Different effects on cell proliferation and migration abilities of endothelial cells by LPA₁ and LPA₃ in mammary tumor FM3A cells.
Kitayoshi M; Fukui R; Tanabe E; Kato K; Yoshikawa K; Fukushima N; Tsujiuchi T
J Recept Signal Transduct Res; 2012 Aug; 32(4):209-13. PubMed ID: 22686188
[TBL] [Abstract][Full Text] [Related]
14. Bioactive lipids lysophosphatidic acid and sphingosine 1-phosphate mediate breast cancer cell biological functions through distinct mechanisms.
Boucharaba A; Guillet B; Menaa F; Hneino M; van Wijnen AJ; Clézardin P; Peyruchaud O
Oncol Res; 2009; 18(4):173-84. PubMed ID: 20112503
[TBL] [Abstract][Full Text] [Related]
15. Lysophosphatidic acid (LPA) enhances the metastatic potential of human colon carcinoma DLD1 cells through LPA1.
Shida D; Kitayama J; Yamaguchi H; Okaji Y; Tsuno NH; Watanabe T; Takuwa Y; Nagawa H
Cancer Res; 2003 Apr; 63(7):1706-11. PubMed ID: 12670925
[TBL] [Abstract][Full Text] [Related]
16. Lysophosphatidic acid receptors determine tumorigenicity and aggressiveness of ovarian cancer cells.
Yu S; Murph MM; Lu Y; Liu S; Hall HS; Liu J; Stephens C; Fang X; Mills GB
J Natl Cancer Inst; 2008 Nov; 100(22):1630-42. PubMed ID: 19001604
[TBL] [Abstract][Full Text] [Related]
17. Lysophosphatidic acid suppresses endothelial cell CD36 expression and promotes angiogenesis via a PKD-1-dependent signaling pathway.
Ren B; Hale J; Srikanthan S; Silverstein RL
Blood; 2011 Jun; 117(22):6036-45. PubMed ID: 21441463
[TBL] [Abstract][Full Text] [Related]
18. MAGI-3 competes with NHERF-2 to negatively regulate LPA2 receptor signaling in colon cancer cells.
Lee SJ; Ritter SL; Zhang H; Shim H; Hall RA; Yun CC
Gastroenterology; 2011 Mar; 140(3):924-34. PubMed ID: 21134377
[TBL] [Abstract][Full Text] [Related]
19. Effects of bisphenol A and 4-nonylphenol on cellular responses through the different induction of LPA receptors in liver epithelial WB-F344 cells.
Dong Y; Araki M; Hirane M; Tanabe E; Fukushima N; Tsujiuchi T
J Recept Signal Transduct Res; 2014 Jun; 34(3):201-4. PubMed ID: 24460192
[TBL] [Abstract][Full Text] [Related]
20. Promotion of cell-invasive activity through the induction of LPA receptor-1 in pancreatic cancer cells.
Fukushima K; Otagaki S; Takahashi K; Minami K; Ishimoto K; Fukushima N; Honoki K; Tsujiuchi T
J Recept Signal Transduct Res; 2018 Aug; 38(4):367-371. PubMed ID: 30396320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
